These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19075964)

  • 1. Allergic inflammation and the oral mucosa.
    Incorvaia C; Frati F; Sensi L; Riario-Sforza GG; Marcucci F
    Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):35-8. PubMed ID: 19075964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances of knowledge on allergic inflammation and the oral mucosa.
    Incorvaia C; Fuiano N; Frati F; Marcucci F
    Recent Pat Inflamm Allergy Drug Discov; 2014; 8(3):173-7. PubMed ID: 25487260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T regulatory cells and their counterparts: masters of immune regulation.
    Ozdemir C; Akdis M; Akdis CA
    Clin Exp Allergy; 2009 May; 39(5):626-39. PubMed ID: 19422105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sublingual immunotherapy on allergic inflammation.
    Incorvaia C; Frati F; Puccinelli P; Marcucci F; Di Cara G; Sensi L; Scurati S; Yacoub MR; Moingeon P
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):167-72. PubMed ID: 18782023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell response to allergens.
    Ozdemir C; Akdis M; Akdis CA
    Chem Immunol Allergy; 2010; 95():22-44. PubMed ID: 20519880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle based-immunotherapy against allergy.
    Gamazo C; Gastaminza G; Ferrer M; Sanz ML; Irache JM
    Immunotherapy; 2014; 6(7):885-97. PubMed ID: 25290419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal dendritic cells in allergy and immunotherapy.
    Novak N; Allam JP
    Allergy; 2011 Jul; 66 Suppl 95():22-4. PubMed ID: 21668846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunization application to allergic disease: sublingual immunotherapy.
    Frati F; Moingeon P; Marcucci F; Puccinelli P; Sensi L; Di Cara G; Incorvaia C
    Allergy Asthma Proc; 2007; 28(1):35-9. PubMed ID: 17390755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sublingual immunotherapy on allergic inflammation: an update.
    Yacoub MR; Colombo G; Marcucci F; Caminati M; Sensi L; Di Cara G; Frati F; Incorvaia C
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):285-91. PubMed ID: 22506880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
    Rolland JM; Prickett S; Gardner LM; O'Hehir RE
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking allergy to autoimmune disease.
    Valenta R; Mittermann I; Werfel T; Garn H; Renz H
    Trends Immunol; 2009 Mar; 30(3):109-16. PubMed ID: 19231288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen-specific immunotherapy.
    Nelson HS; Norman PS
    Chem Immunol Allergy; 2014; 100():333-8. PubMed ID: 24925414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
    Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
    Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
    Saint-Lu N; Tourdot S; Razafindratsita A; Mascarell L; Berjont N; Chabre H; Louise A; Van Overtvelt L; Moingeon P
    Allergy; 2009 Jul; 64(7):1003-13. PubMed ID: 19220212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy.
    Moingeon P; Lombardi V; Baron-Bodo V; Mascarell L
    J Allergy Clin Immunol Pract; 2017; 5(1):23-31. PubMed ID: 28065340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TH1/TH2 paradigm in allergy.
    Maggi E
    Immunotechnology; 1998 Jan; 3(4):233-44. PubMed ID: 9530557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renaissance of the blocking antibody concept in type I allergy.
    Flicker S; Valenta R
    Int Arch Allergy Immunol; 2003 Sep; 132(1):13-24. PubMed ID: 14555854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.